Ufp Technologies (UFPT) Gains from Investment Securities (2022 - 2025)
Ufp Technologies (UFPT) posted Gains from Investment Securities of -$528000.0 for Q4 2025, down 300.76% on a QoQ basis from $263000.0 in Q3 2025, and up 15.52% year-over-year from -$457063.7 in Q4 2024.
Ufp Technologies (UFPT) Gains from Investment Securities (2022 - 2025) Analysis & Trends
Ufp Technologies' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$528000.0 for Q4 2025.
- Quarterly Gains from Investment Securities rose 15.52% year-over-year to -$528000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2000.0 (down 101.75% YoY) and the FY2025 annual result came in at $261000.0, up 193.26% from the prior year.
- Gains from Investment Securities was -$528000.0 for Q4 2025 at Ufp Technologies, down from $263000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.0 million in Q2 2022 and bottomed at -$9.3 million in Q4 2022.
- A 4-year average of $258466.7 and a median of $238000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities surged 102.55% — and 2024, when it slumped 362.61%.
- Ufp Technologies' Gains from Investment Securities stood at -$9.3 million in 2022, then jumped by 102.55% to $238000.0 in 2023, then slumped by 362.61% to -$625000.0 in 2024, then gained by 15.52% to -$528000.0 in 2025.
- Business Quant data shows UFPT's Gains from Investment Securities at -$528000.0 in Q4 2025, $263000.0 in Q3 2025, and $263000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Ufp Technologies | 1.92 Bn | 1.90 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -528,000.00 |
| Dec 31, 2025 | -528,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | -625,000.00 |
| Dec 31, 2024 | -625,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Jun 30, 2024 | 238,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Mar 31, 2024 | 238,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Sep 30, 2023 | 238,000.00 |